ST- Gliptin M 50/500

Description

ST- Gliptin M 50/500 Sitagliptin Phosphate and Metformin Hydrochloride Tablets ST- Gliptin M 50/500 are two different medications commonly used in the management of type 2 diabetes. They are often prescribed in combination to help control blood sugar levels effectively. Let's take a closer look at each of these medications: Sitagliptin is the active ingredient in medications like Januvia and is classified as a dipeptidyl peptidase-4 (DPP-4) inhibitor. It works by inhibiting the enzyme DPP-4, which breaks down incretin hormones like GLP-1 (glucagon-like peptide-1). Incretin hormones play a role in regulating blood sugar levels by stimulating insulin release and decreasing glucagon production, both of which lower blood sugar. Sitagliptin helps increase the levels of these incretin hormones in the body, leading to improved blood glucose control, especially after meals. It is typically taken as an oral tablet once daily. Metformin is one of the most commonly prescribed medications for type 2 diabetes. It belongs to the class of drugs called biguanides. Metformin primarily works by reducing the production of glucose by the liver and increasing the sensitivity of muscle cells to insulin, allowing better glucose uptake from the bloodstream. Additionally, metformin may help with weight management and can improve lipid profiles. It is typically taken as an oral tablet and is available in both immediate-release and extended-release formulations. The combination of ST- Gliptin M 50/500 is often prescribed to individuals with type 2 diabetes when metformin alone is insufficient to control blood sugar levels. This combination offers complementary mechanisms of action: metformin primarily targets insulin resistance and liver glucose production, while sitagliptin enhances the effects of incretin hormones. By using these two medications together, better glycemic control can be achieved.